Co-supplementation of single and multi doses of vitamins C and E ameliorates cisplatin-induced acute renal failure in mice

Experimental and Toxicologic Pathology

Volumn 61, Issue 6, 2009, Pages 565-571

  Ajith, T A ^a   Abhishek, G ^a   Roshny, D ^a   Sudheesh, N P ^b  

^a AMALA INSTITUTE OF MEDICAL SCIENCES   (India)

^b AMALA CANCER RESEARCH CENTRE   (India)

Author keywords

Antioxidants; Cisplatin; Nephrotoxicity; Vitamin C; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CISPLATIN; CREATININE; GLUTATHIONE; MALONALDEHYDE; UREA;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFICACY; MALE; MONOTHERAPY; MOUSE; MULTIPLE DRUG DOSE; NONHUMAN; RENAL PROTECTION; SINGLE DRUG DOSE; UREA BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; ASCORBIC ACID; CISPLATIN; GLUTATHIONE; KIDNEY FAILURE, ACUTE; MALE; MALONDIALDEHYDE; MICE; VITAMIN E;

ANIMALIA; MUS;

EID: 71549118584     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etp.2008.12.002     Document Type: Article

References (39)

1. Ajith T.A., Jose N., and Janardhanan K.K. Amelioration of cisplatin-induced nephrotoxicity in mice by ethyl acetate extract of a polypore fungus, Phellinus rimosus. J Exp Clin Cancer Res 21 (2002) 487-491
2. Ajith T.A., Usha S., and Nivitha V. Ascorbic acid and alpha tocopherol protect anticancer drug cisplatin-induced nephrotoxicity in mice: a comparative study. Clin Chim Acta 375 (2007) 82-86
3. Appenroth D., Fröb S., Kersten L., Splinter F.-K., and Winnefeld K. Protective effects of vitamin E and C on cisplatin nephrotoxicity in developing rats. Arch Toxicol 71 (1997) 677-683
4. Babu E., Gopalkrishnan V.K., Sriganth N.P., Gopalkrishnan R., and Sakthisekharan D. Cisplatin-induced nephrotoxicity and the modulating effect of glutathione ester. Mol Cell Biochem 144 (1995) 7-11
5. Boogaard P.J., Lempers E.L., Mulder G.J., and Meerman J.H.N. 4-methylthiobenzoic acid reduces cisplatin nephrotoxicity in rats without compromising anti-tumor activity. Biochem Pharmacol 41 (1991) 1997-2003
6. Braun N., Frank J., Biesalski H.K., and Risler T. Antioxidative treatment retards progression of idiopathic membranous nephropathy. Nephron 86 (2000) 208-209
7. Capizzi R.L. Amifostine reduces the incidence of cumulative nephrotoxicity from cisplatin: laboratory and clinical aspects. Semin Oncol 26 (1999) 72-81
8. Cetin R., Devrim E., Kilicoglu B., Avei A., Candir O., and Durak I. Cisplatin impairs antioxidant system and causes oxidation in rat kidney tissues: possible protective roles of natural antioxidant foods. J Appl Toxicol 26 (2006) 42-46
9. Chabner B.A., Ryan D.P., Paz-Ares L., Garcia-Carbonevo R., and Calabresi P. Antineoplastic agents. In: Hardman J.G., Limbird L.E., and Gilman A.G. (Eds). Goodman and Gilman's the pharmacological basis of therapeutics (2001), McGraw-Hill Companies Inc, USA 1389-1459
10. Chen J., He J., Ogden L., Batuman V., and Whelton P. Relationship of serum antioxidant vitamins to serum creatinine in the US population. Am J Kidney Dis 39 (2002) 460-468
11. Cornelison T.L., and Reed E. Nephrotoxicity and hydration management for cisplatin, carboplatin, and ormaplatin. Gynecol Oncol 50 (1993) 147-158
12. Daugaard G., and Abildgaard U. Cisplatin nephrotoxicity: a review. Cancer Chemother Pharmacol 25 (1989) 1-9
13. Davis C.A., Nick H.S., and Agarwal A. Manganese superoxide dismutase attenuates cisplatin-induced renal injury: importance of superoxide. J Am Soc Nephrol 12 (2001) 2683-2690
14. Dillioglugil M.O., Maral Kir H., Gulkac M.D., Ozon Kanli A., Ozdogan H.K., Acar O., et al. Protective effects of increasing vitamin E and A doses on cisplatin-induced oxidative damage to kidney tissue in rats. Urol Int 75 (2005) 340-344
15. Gandara D.R., Perez E.A., Wiebe V., and De Gregorio M.W. Cisplatin chemoprotection and rescue. Pharmacologic modulation toxicity. Semin Oncol 18 (1991) 49-55
16. Grover B., Auberger C., Sarangarajan R., and Cacini W. Functional impairment of renal organic cation transport in experimental diabetes. Pharmacol Toxicol 90 (2002) 181-186
17. Halliwell B., and Chirico S. Lipid peroxidation: its mechanism, measurement and significance. Am J Clin Nutr 57 (1993) 715S-725S
18. Hamers F.P.T., Brakkee J.H., Cavalletti E., and Tedeschi L. Reduced glutathione protects against cisplatin-induced neurotoxicity in rats. Cancer Res 53 (1993) 544-549
19. Hamers F.P.T., Gispen W.H., and Neijit J.P. Neurotoxic side effects of cisplatin. Eur J Cancer 27 (1991) 372-376
20. Hanigan M.H., Deng M., Zhang Jr. L., Tayler P.T., and Lapus M.G. Stress response inhibits the nephrotoxicity of cisplatin. Am J Physiol Renal Physiol 288 (2005) F125-F132
21. Hoffer A. Ascorbic acid and toxicity. N Engl J Med 285 (1971) 635-636
22. Jiang M., Wei Q., Pabla N., Dong G., Wang C.Y., Yang T., et al. Effects of hydroxyl radical scavenging on cisplatin-induced p53 activation, tubular cell apoptosis and nephrotoxicity. Biochem Pharmacol 73 (2007) 1499-1510
23. Jones M.M., Basinger M.A., and Holscher M.A. Control of the nephrotoxicity of cisplatin by clinically used sulfur-containing compounds. Fund Appl Toxicol 18 (1992) 176-181
24. Karimi G., Ramezani M., and Tahoonian Z. Cisplatin nephrotoxicity and protection by milk thistle extract in rats. Evid Based Complement Alternat Med 2 (2005) 383-386
25. Kawai Y., Nakao T., Kunimura N., Kohda Y., and Gemba M. Relationship of intracellular calcium and oxygen radicals to cisplatin-related renal cell injury. J Pharmacol Sci 100 (2006) 65-72
26. Lowry H.D., Rosenbrough N.J., Farr A.L., and Randall R.J. Protein measurement with Folin phenol reagent. J Biol Chem 193 (1951) 265-275
27. Meydani M. Vitamin E. Lancet 345 (1995) 170-175
28. Moron M.A., Depierre J.W., and Mannervik B. Levels of glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta 582 (1979) 67-78
29. Naziroglu M., Karaoglu A., and Aksoy A.O. Selenium and high dose vitamin E administration protects cisplatin-induced oxidative damage to renal and lens tissue in rats. Toxicology 195 (2004) 221-230
30. Ohkawa H., Ohishi N., and Yagi K. Assay for lipid peroxide in animal tissues by thiobarbituric acid reaction. Anal Biochem 95 (1979) 351-358
31. Ramesh G., Kimball S.R., Jefferson L.S., and Reeves W.B. Endotoxin and cisplatin synergistically stimulate TNF-α production by renal epithelial cells. Am J Physiol Renal Physiol 292 (2007) F812-F819
32. Rana S.V.S., Allen T., and Singh R. Inevitable glutathione, then and now. Ind J Exp Biol 40 (2002) 706-716
33. Ravi R.S., Somini S.M., and Rybak L.P. Mechanism of cisplatin ototoxicity. Antioxidant system. Pharmacol Toxicol 76 (1995) 386-394
34. Rybak L.P., Ravi P.R., and Somani S.M. Mechanism of protection by diethyldithiocarbamate against cisplatin ototoxicity: antioxidant system. Fund Appl Toxicol 26 (1995) 293-300
35. Somani S.M., Husain K., Whitworth C., Trammell G.L., and Malafa M. Rybak LP Dose-dependent protection by lipoic acid against cisplatin-induced nephrotoxicity in rats: antioxidant defense system. Pharmacol Toxicol 86 (2000) 234-241
36. Townsend D.M., Deng M., Zhang L., Lapus M.G., and Hanigan M.H. Metabolism of cisplatin to a nephrotoxin in proximal tubule cells. J Am Soc Nephrol 14 (2003) 1-10
37. Weijl N.I., Elsendoorn T.J., Lentjes E.G., Hopman G.D., Wipkink-Bakker A., Zwinderman A.H., et al. Supplementation with antioxidant micronutrients and chemotherapy-induced toxicity in cancer patients treated with cisplatin-based chemotherapy: a randomized, double-blind, placebo-controlled study. Eur J Cancer 40 (2004) 1713-1723
38. Wolfgang G.H.I., Dominic M.A., Walsh K.M., Hoeschele J.D., and Pegg D.G. Comparative nephrotoxicity of a novel platinum compound, cisplatin and carboplatin in male wistar rats. Fund Appl Toxicol 22 (1994) 73-79
39. Yilmaz H.R., Iraz M., Sogut S., Ozyurt H., Yildirim Z., Akyol O., et al. The effects of erdosteine on the activities of some metabolic enzymes during cisplatin-induced nephrotoxicity in rats. Pharmacol Res 50 (2004) 287-290